Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Korean firm bids CHF1.5bn for Swiss pharma supplier Polypeptide
The company is offering CHF44.31 per share in cash, valuing Polypeptide at around CHF1.5 billion. Polypeptide's board of directors supports the offer, both companies announced on Monday. The major shareholder, Draupnir Holding, which holds just…
Bristol Partners With Nvidia on AI Factory for Drug Development
Bristol Myers Squibb Co. is expanding its partnership with Nvidia Corp. to boost the computing power of an AI factory that the drugmaker say it's using to create new medicines more quickly. The tie-up is one of several between the chipmaker and…
Chemists demand fair competition in pharma market amid online sales concerns
The All India Organisation of Chemists and Druggists (AIOCD) on Sunday (July 19, 2026) demanded that the government ensure an equitable ecosystem for all the players to sustain in the market by ensuring a level playing field. At its sixth…
Private banks drag indices lower; PSU banks, pharma cushion losses
Markets closed lower on Monday as disappointing net interest margins from a key private-sector lender and renewed geopolitical tensions in the Middle East kept investors cautious throughout the session, even as public-sector banks and pharma stocks…
Stocks to watch: JSW Steel, Alembic Pharma, Cipla, Laser Power, 5Paisa, Prestige Estates, NBCC (India)
The board of JSW Steel Ltd has approved the company's participation in the proposed IPO of JSW One Platforms Ltd (JOPL) as a promoter selling shareholder. The company plans to sell equity shares worth up to ₹811 crore through an offer for…
NervGen Pharma (NASDAQ:NGEN) Upgraded by Wall Street Zen to 'Hold' Rating
NervGen Pharma (NASDAQ:NGEN - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'sell' rating to a 'hold' rating in a research note issued on Monday. A number of other brokerages have also recently weighed in on NGEN.
Hsbc Holdings PLC Acquires 1,486,020 Shares of Royalty Pharma PLC $RPRX
Hsbc Holdings PLC lifted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 2,562.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,544,018 shares of…
Fifth Third Bancorp Purchases Shares of 49,729 BridgeBio Pharma, Inc. $BBIO
Fifth Third Bancorp purchased a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund…
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Receives Average Rating of 'Hold' from Brokerages
Shares of OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO - Get Free Report) have been assigned an average recommendation of 'Hold' from the five ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst…
Jennison Associates LLC Cuts Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
Jennison Associates LLC cut its position in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 21.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned…
Sensex, Nifty End In Red As Bank Nifty Slumps 0.98% On Mixed Q1 Earnings; Asian Markets Trade Mixed Amid Middle East Tensions
Indian equity benchmarks closed lower on Monday, weighed down by weak performances across IT, banking, and auto stocks, even as select defensive sectors managed to buck the trend. The Nifty 50 settled at 24,238.50, down 95.80 points, or 0.39%…
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Thursday's announcement that Eli Lilly will acquire AtaiBeckley, a clinical-stage maker of psychedelic drugs, for up to $3.8 billion indicates Big Pharma's increasing embrace of a long-stigmatized class of medications as alternatives for treating…
PJP vs. IYH: Which Healthcare ETF Is the Better Buy?
The iShares U.S. Healthcare ETF (IYH 0.47%) provides broad exposure to the medical sector at a lower cost, while the Invesco Pharmaceuticals ETF (PJP +0.28%) offers a more concentrated bet on drug development. While both funds target American…
10 Companies Enter Rs 1 Trillion Club, 6 Exit
The number of companies with a market capitalisation of Rs 1 trillion or more rose to 114 in 2026, from 110 in the previous year. Ten companies entered the Rs 1 trillion club, while six exited it during the year. Companies that entered the club in…
How AI is supercharging drug development
Artificial intelligence is dramatically speeding up drug development — and a proprietary survey shows how it's priming a bigger automation push that's changing the trajectory of early stage pharma research. Why it matters: The TD Cowen…
Receive a Daily briefing on Pharma Industry News
Get Started